Third-generation antiviral drugs include Icloxa and vasiclovir. Currently, antiviral drugs are mainly used for hepatitis viruses as well as viral infections, among which the third-generation antiviral drugs include Gisandia (also known as Icloxa), which is mainly used for treating adult patients with chronic hepatitis C virus infection. Gizumab also treats patients with hepatitis C cirrhosis, using Gizumab alone for patients without cirrhosis or with compensated cirrhosis, and combining Gizumab and ribavirin for patients with decompensated cirrhosis. Compared to the first generation of antiviral drugs Ji I and the second generation of antiviral drugs Ji II on the treatment of genotypes of different populations, Jisandai is suitable for the treatment of genotype 1 to 6 all chronic hepatitis C virus adult infected patients, is currently the best hepatitis C treatment drugs, and in the clinical application of the treatment of the patients did not appear serious side effects. There is a difference between the three generations of drugs, and it is recommended that hepatitis patients take regular medication under the guidance of a doctor.